FORM SC-13D

Company

PharmaCyte Biotech, Inc.

Filed

November 22, 2023

Accession Number

0001683168-23-008419

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →